KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Encompass Health (EHC) EBIAT (2016 - 2025)

Encompass Health (EHC) has disclosed EBIAT for 17 consecutive years, with $202.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBIAT rose 24.19% year-over-year to $202.3 million, compared with a TTM value of $759.6 million through Dec 2025, up 27.32%, and an annual FY2025 reading of $760.1 million, up 27.41% over the prior year.
  • EBIAT was $202.3 million for Q4 2025 at Encompass Health, up from $175.0 million in the prior quarter.
  • Across five years, EBIAT topped out at $206.3 million in Q4 2021 and bottomed at $20.1 million in Q4 2023.
  • Average EBIAT over 5 years is $131.3 million, with a median of $136.4 million recorded in 2021.
  • The sharpest move saw EBIAT plummeted 84.42% in 2023, then skyrocketed 710.45% in 2024.
  • Year by year, EBIAT stood at $206.3 million in 2021, then plummeted by 37.47% to $129.0 million in 2022, then tumbled by 84.42% to $20.1 million in 2023, then surged by 710.45% to $162.9 million in 2024, then grew by 24.19% to $202.3 million in 2025.
  • Business Quant data shows EBIAT for EHC at $202.3 million in Q4 2025, $175.0 million in Q3 2025, and $185.8 million in Q2 2025.